Proteome Sciences plc (LON:PRM – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.40 ($0.03), with a volume of 1232701 shares trading hands. The stock had previously closed at GBX 2.76 ($0.03).
Proteome Sciences Stock Performance
The stock’s 50 day moving average is GBX 2.80 and its 200 day moving average is GBX 3.29. The company has a market capitalization of £7.08 million, a PE ratio of -286.40 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- Retail Stocks Investing, Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Small Caps With Big Return Potential
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
